Company
Quarterly Report 3rd Quarter 2019
Evonik has published its quarterly report Q3 2019 on November 5, 2019. You can access further information here. ... MORE
Company
Annual Shareholders' Meeting 2019
The Annual Shareholders' Meeting 2019 of Evonik Industries AG took place on May 28, 2019 at 10 a.m. (Central European Summer Time - CEST) at the Grugahalle in Essen (Germany). You can find further information here. ... MORE
Company
Quarterly Report 2nd Quarter 2019
Evonik has published its quarterly report Q2 2019 on August 1, 2019. You can access further information here. ... MORE
Further Information
Company
Events & Presentations
Here you will find dates, information and presentations on our events. ... MORE
Company
Analysts' estimates
Evonik Industries AG is covered by German and international financial analysts, who provide their own research analyses and earnings estimates in respect of the company. ... MORE
Company
News & Reports
Here you can find "Investor Relations News" with the latest news from our company, plus our most recent interim reports, annual reports and corporate responsibility reports. ... MORE
Reporting 2019 / 2020
-
November 5, 2019Quarterly Report Q3 2019
-
March 4, 2020Quarterly Report Q4 2019
-
April 1, 2020Capital Markets Day 2020London
-
May 7, 2020Quarterly Report Q1 2020
-
May 27, 2020Annual Shareholders' Meeting
-
August 4, 2020Quarterly Report Q2 2020
-
November 3, 2020Quarterly Report Q3 2020
Investor Relations
Nov 05, 2019
Evonik confirms full-year earnings outlook despite ongoing weakness in global economy
Evonik is sticking to its full-year earnings outlook despite an ongoing weakness in the global economy. ... MORE
Investor Relations
Oct 30, 2019
Evonik and Dow develop industrial-scale direct synthesis of propylene glycol from propylene and hydrogen peroxide
Dow and Evonik have entered into an exclusive technology partnership ... MORE
Investor Relations
Aug 02, 2019
Evonik acquisition of PeroxyChem delayed by FTC lawsuit
Evonik will vigorously defend itself against the action of the Federal Trade Commission, which today announced it will file a lawsuit seeking to block Evonik’s proposed acquisition of PeroxyChem, a worldwide manufacturer of specialty peroxygen chemistries. ... MORE
Investor Relations
Aug 01, 2019
Evonik closes sale of Methacrylates business
Evonik has closed the sale of its Methacrylates business as the next step in its consistent focus on specialty chemicals. ... MORE
Investor Relations
Aug 01, 2019
Evonik sticks to full-year outlook despite cooling economy
Evonik is sticking to its full-year outlook despite an increasingly gloomy economic environment ... MORE
Investor Relations
Jul 10, 2019
Unique facility begins production of omega-3 fatty acids for sustainable salmon farming
Following a construction period of just two years, a joint venture between Evonik and the Dutch company DSM has today commissioned its globally unique production plant in the US ... MORE
Further Information
Company
Financial data
Evonik is active in over 100 countries around the world. In fiscal 2018 more than 36,000 employees generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.6 billion. ... MORE
Company
Bonds & Rating
Evonik maintains a centralized approach to financing. Liabilities for credit and loans are fully guaranteed by Evonik Industries AG. ... MORE
Company
Key Figures Share
Here you find information about Evonik shares. ... MORE
Company
Contact & Service
You can find the contacts in the Investor Relations Department here. ... MORE
Company
Disclaimer
Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained. ... MORE
Company
Corporate Governance
As a globally active company, we have to comply with a wide range of statutory regulations and cultural standards. ... MORE
Company
Sustainable Investment (SRI)
We accept responsibility for our businesses, our employees, the environment and the society. ... MORE